Results 101 to 110 of about 9,946,516 (158)
Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. [PDF]
Huang CY +8 more
europepmc +1 more source
Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient
P. Fava +3 more
semanticscholar +1 more source
Long non-coding RNA H19 as a prognostic biomarker for oral squamous cell carcinoma. [PDF]
Kumar K +8 more
europepmc +1 more source
Clinical Heterogeneity Associated with MYO7A Variants Relies on Affected Domains. [PDF]
Joo SY +11 more
europepmc +1 more source
Clinical significance of Beta-2 glycoprotein I antibodies in BcrAbl (-) myeloproliferative neoplasms
Background: Beta-2 glycoprotein I antibodies (B2-GPI Ab) are significant markers of thrombosis in otoimmune diseases. No literature has been found in Bcr Abl (-) MPNs to exclude the risk of hereditary thrombophilia and to investigate the association of ...
Unlu, Ali +2 more
core
Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells. [PDF]
Wang J +8 more
europepmc +1 more source
The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors. [PDF]
Pouloudi D +6 more
europepmc +1 more source

